Curanex Pharmaceuticals Inc (CURX) Stock

NASDAQ: CURXHealthcare company in the biotechnology industry, based in Jericho, NY.

Curanex Pharmaceuticals stock price chart

CURX interactive chart →

CURX stock quote & key statistics

Curanex Pharmaceuticals earnings per share

Income →
Earnings per share

Curanex Pharmaceuticals revenue & net income

Income →
RevenueNet income

Curanex Pharmaceuticals annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$4.2M-$2.22
FY2024$0-$361,506—
FY2023$0-$19,198—
FY2022$26,000-$20,233—

Fiscal year ending December 31. Source: company filings via EODHD.

About Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.

Curanex Pharmaceuticals stock FAQ

What is the Curanex Pharmaceuticals stock ticker symbol?

Curanex Pharmaceuticals Inc trades on the NASDAQ under the ticker symbol CURX.

What sector and industry is Curanex Pharmaceuticals in?

Curanex Pharmaceuticals Inc is classified in the Healthcare sector, Biotechnology industry.

How many employees does Curanex Pharmaceuticals have?

Curanex Pharmaceuticals Inc has about 6 full-time employees.

What were Curanex Pharmaceuticals's revenue and earnings last fiscal year?

Curanex Pharmaceuticals reported revenue of $0 and net income of -$4.2M in fiscal 2025, with earnings per share of -$2.22.

When did Curanex Pharmaceuticals go public?

Curanex Pharmaceuticals stock began trading on August 26, 2025.

Biotechnology stocks

All Healthcare stocks →